Insider Selling: United Therapeutics (NASDAQ:UTHR) CEO Sells $1,588,920.00 in Stock

[ad_1]

United Therapeutics Corporation (NASDAQ:UTHR – Get Free Report) CEO Martine Rothblatt sold 4,000 shares of the stock in a transaction dated Thursday, September 11th. The stock was sold at an average price of $397.23, for a total value of $1,588,920.00. Following the completion of the sale, the chief executive officer directly owned 130 shares of the company’s stock, valued at approximately $51,639.90. This represents a 96.85% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website.

[ad_2]

Source link